Study of health and wellbeing after retinoblastoma treatment
Part of Cancer, Eyes & vision clinical trials.
This study looks at long-term health outcomes—how patients are doing physically and in daily life—after treatment for retinoblastoma. It may help doctors understand what support or follow-up care could be most helpful after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have retinoblastoma in one or both eyes
- You were diagnosed between birth and about age 18
- Your diagnosis date is on or after January 1, 2008
- If treatment already ended, you must be at least 6 months past the last treatment date
- If you have not started treatment yet, you can join before treatment begins
- You (or your parent/guardian) can communicate in English, French, or Spanish and can give consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how retinoblastoma and its treatment affect thinking skills and quality of life over time. It may help doctors better support survivors and their families.
This trial looks at care recommendations for children with retinoblastoma (a childhood eye cancer). It may help standardize the best treatment approach for different patterns of tumor spread.
This Phase 2 study tests a way to deliver cancer treatment directly inside the eye to treat retinoblastoma. It may help shrink the tumor while limiting treatment to the eye when possible.
This study looks at gene changes in retinoblastoma to understand why some tumors spread outside the eye. It may help find better ways to predict and treat the disease.
This study looks at patients who have received additional cancer treatment after their initial retinoblastoma (eye cancer) therapy and tracks their recovery for at least one year. The research aims to understand how well this follow-up treatment works and what happens to patients over time.
This trial studies whether newer “save-the-eye” treatment plans can control retinoblastoma (eye cancer) while keeping vision as good as possible. It compares different conservative treatment strategies depending on how the tumor looks and where it is.
Hear when a new Retinoblastoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.